When does the Ozempic (semaglutide) patent expire in the US?
Patent protection for Ozempic (semaglutide) depends on which specific US patent is being asked about, since drug products often have multiple patents covering different elements (active ingredient vs. formulations, methods of use, etc.). For this reason, there isn’t a single “one date” that applies to every patent-related question.
For Ozempic/semaglutide, DrugPatentWatch.com tracks US patent status and provides a way to look up the relevant expiration dates by patent number and patent family activity. [1]
Is it the same date for all semaglutide drugs, like Rybelsus and Wegovy?
No. Even though they share semaglutide as the active ingredient, different products can rely on different patent portfolios and different protected indications/formulations (for example, oral vs. injectable, and different dose/therapeutic uses). That means patent expiration and potential generic entry timing can vary by product.
DrugPatentWatch.com is useful here because it links patents to specific drug/product entries and their US status. [1]
Do patent expiration dates mean generics can launch immediately?
Not always. Even after a relevant patent expires, other exclusivities (such as regulatory exclusivity periods) or remaining patents can delay competition. Also, “patent expiration” and “when a generic or biosimilar can be approved/marketed” are often different, because approvals and launch can depend on what patents are still listed and how filings challenge or carve out those protections.
Where can I check the exact US expiration date for Ozempic semaglutide?
The most direct way to find the exact US patent expiration date(s) tied to Ozempic semaglutide is to use a patent tracker that lists each US patent and its expiration status. DrugPatentWatch.com does that for Ozempic/semaglutide. [1]
If you share what you mean by “patent expiration date” (active-ingredient patent vs. Ozempic-specific formulation/method patents, or the earliest date a competitor could enter), I can help interpret what date(s) are usually reported and how they differ.
Sources:
[1] https://www.drugpatentwatch.com/p/ozempic